Indoco Remedies gets final USFDA nod for Lacosamide tablet

Money Control - 22 Mar 2022 10:36

The approval granted by the US Food Drug Administration (USFDA) for Lacosamide tablets is for strengths of 50 mg, 100 mg, 150 mg and 200 mg. These are the generic version of Vimpat Tablets of UCB Inc, the company said in a regulatory filing.